The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-4-(7-chloro-4-(3-methylmorpholino)quinazolin-2-yl)-N-hydroxybenzamide ID: ALA4872978
PubChem CID: 164625280
Max Phase: Preclinical
Molecular Formula: C20H19ClN4O3
Molecular Weight: 398.85
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H]1COCCN1c1nc(-c2ccc(C(=O)NO)cc2)nc2cc(Cl)ccc12
Standard InChI: InChI=1S/C20H19ClN4O3/c1-12-11-28-9-8-25(12)19-16-7-6-15(21)10-17(16)22-18(23-19)13-2-4-14(5-3-13)20(26)24-27/h2-7,10,12,27H,8-9,11H2,1H3,(H,24,26)/t12-/m1/s1
Standard InChI Key: MEWOWLRYSDUDAO-GFCCVEGCSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
38.0764 -4.2180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0752 -5.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7833 -5.4465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7815 -3.8091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4901 -4.2144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4909 -5.0334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1994 -5.4405 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.9077 -5.0296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9029 -4.2075 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.1938 -3.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6170 -5.4355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6153 -6.2497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3237 -6.6555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.0308 -6.2441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.0250 -5.4227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3160 -5.0206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.7406 -6.6490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.7449 -7.4662 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.4462 -6.2367 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
45.1560 -6.6416 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.1895 -2.9870 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.8994 -2.5778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8970 -1.7641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1890 -1.3555 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.4816 -1.7666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4824 -2.5864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6076 -2.9856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3672 -5.4456 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
8 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
14 17 1 0
17 18 2 0
17 19 1 0
19 20 1 0
10 21 1 0
21 22 1 0
21 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
22 27 1 1
2 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 398.85Molecular Weight (Monoisotopic): 398.1146AlogP: 3.29#Rotatable Bonds: 3Polar Surface Area: 87.58Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.98CX Basic pKa: 3.98CX LogP: 3.95CX LogD: 3.94Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -1.39
References 1. Yao D, Jiang J, Zhang H, Huang Y, Huang J, Wang J.. (2021) Design, synthesis and biological evaluation of dual mTOR/HDAC6 inhibitors in MDA-MB-231 cells., 47 [PMID:34139324 ] [10.1016/j.bmcl.2021.128204 ]